Suppr超能文献

生活方式干预对非酒精性脂肪性肝病发病机制的影响。

Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease.

机构信息

Department of Internal Medicine, Medical Research and Clinical Studies Institute, National Research Center, Giza 12311, Egypt.

出版信息

World J Gastroenterol. 2024 May 28;30(20):2633-2637. doi: 10.3748/wjg.v30.i20.2633.

Abstract

This editorial builds on the article titled "Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease" by Zeng . We carried out a critical examination of nonalcoholic fatty liver disease (NAFLD) pathogenesis and how lifestyle interventions could facilitate disease resolution, particularly highlighting that non-alcoholic steatohepatitis (NASH) is a severe form of NAFLD. Our discussion details that weight loss is a pivotal factor in disease outcomes: A 3%-5% reduction is enough for resolution in 50% of non-obese individuals, while a 7%-10% reduction achieves similar benefits in obese individuals, as demonstrated by magnetic resonance spectroscopy. Additionally, the editorial underscores that such lifestyle changes are instrumental not only in resolving NAFLD but also in reversing hepatic steatosis and inflammation. These insights, derived from the research, emphasize the critical role of personalized lifestyle modifications in halting the progression of NAFLD to NASH and even reversing fibrosis, thus offering a template for effective patient management.

摘要

这篇社论是对曾发表的题为“建立和验证非酒精性脂肪性肝病生活方式干预依从性预测系统”的文章的扩展。我们对非酒精性脂肪性肝病 (NAFLD) 的发病机制以及生活方式干预如何促进疾病的缓解进行了批判性的检查,特别强调非酒精性脂肪性肝炎 (NASH) 是一种严重的 NAFLD 形式。我们的讨论详细说明了体重减轻是疾病结果的关键因素:对于 50%的非肥胖个体,减轻 3%-5%就足以解决问题,而对于肥胖个体,减轻 7%-10%则可达到类似的效果,这一点已经通过磁共振光谱法得到了证实。此外,社论还强调,这些生活方式的改变不仅有助于解决 NAFLD,还可以逆转肝脂肪变性和炎症。这些研究结果强调了个性化生活方式改变在阻止 NAFLD 进展为 NASH 甚至逆转纤维化方面的关键作用,为有效的患者管理提供了模板。

相似文献

1
Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease.
World J Gastroenterol. 2024 May 28;30(20):2633-2637. doi: 10.3748/wjg.v30.i20.2633.
2
Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need.
World J Gastroenterol. 2024 Jul 7;30(25):3143-3146. doi: 10.3748/wjg.v30.i25.3143.
3
Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
Am J Physiol Gastrointest Liver Physiol. 2018 Sep 1;315(3):G329-G338. doi: 10.1152/ajpgi.00044.2018. Epub 2018 Jun 7.
6
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.
8
Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
Metabolism. 2016 Aug;65(8):1161-71. doi: 10.1016/j.metabol.2016.01.008. Epub 2016 Jan 20.
9
Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
Z Gastroenterol. 2019 Apr;57(4):508-517. doi: 10.1055/a-0784-8827. Epub 2019 Apr 9.
10
Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease.
Arch Med Res. 2021 Jan;52(1):25-37. doi: 10.1016/j.arcmed.2020.11.010. Epub 2020 Dec 14.

引用本文的文献

1
Targeting Metabolism: Innovative Therapies for MASLD Unveiled.
Int J Mol Sci. 2025 Apr 25;26(9):4077. doi: 10.3390/ijms26094077.
2
Delaying liver aging: Analysis of structural and functional alterations.
World J Gastroenterol. 2025 Apr 21;31(15):103773. doi: 10.3748/wjg.v31.i15.103773.
3
MRI-PDFF Assessment of Intrahepatic Fat Changes Post-Bariatric Surgery: A Systematic Literature Review.
Medicina (Kaunas). 2024 Dec 4;60(12):2003. doi: 10.3390/medicina60122003.
4
Healthy Lifestyle and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study of the Efficacy of Fatty Liver Regression.
Clin Transl Gastroenterol. 2025 Feb 1;16(2):e00806. doi: 10.14309/ctg.0000000000000806.

本文引用的文献

2
The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States.
J Clin Exp Hepatol. 2023 May-Jun;13(3):454-467. doi: 10.1016/j.jceh.2022.12.005. Epub 2022 Dec 22.
3
A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease.
Clin Gastroenterol Hepatol. 2022 Jun;20(6):e1456-e1468. doi: 10.1016/j.cgh.2021.06.048. Epub 2021 Jul 3.
4
Mechanisms and disease consequences of nonalcoholic fatty liver disease.
Cell. 2021 May 13;184(10):2537-2564. doi: 10.1016/j.cell.2021.04.015.
5
Dietary patterns and risk of non-alcoholic fatty liver disease.
BMC Gastroenterol. 2021 Jan 28;21(1):41. doi: 10.1186/s12876-021-01612-z.
8
Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD).
Oxid Med Cell Longev. 2020 Oct 19;2020:1617805. doi: 10.1155/2020/1617805. eCollection 2020.
10
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
Free Radic Biol Med. 2019 Nov 20;144:293-309. doi: 10.1016/j.freeradbiomed.2019.05.029. Epub 2019 May 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验